PREVIOUS QUESTION:

 

NEXT QUESTION:

 

What drugs have shown promise in treating lung cancer?

ANSWER

Drugs that target growth factor receptors, such as afatinib (Gilotrif), erlotinib (Tarceva), necitumumab (Portrazza), osimertinib (Tagrisso), bevacizumab (Avastin), and ramucirumab (Cyramza) have shown significant activity in helping to control advanced lung cancer. Gefitinib (Iressa) has been most recently approved as a first-line treatment of patients with metastatic NSCLC and offers another targeted therapy for tumors with specific growth factor receptor mutations.

SOURCES: 

National Cancer Institute. 

National Institutes of Health. 

WebMD Medical Reference from the American College of Physicians: “Section 12 VIII Lung Cancer.”

News release, FDA.

American Cancer Society.

American Lung Association. 

Reviewed by Carol DerSarkissian on February 05, 2019

SOURCES: 

National Cancer Institute. 

National Institutes of Health. 

WebMD Medical Reference from the American College of Physicians: “Section 12 VIII Lung Cancer.”

News release, FDA.

American Cancer Society.

American Lung Association. 

Reviewed by Carol DerSarkissian on February 05, 2019

NEXT QUESTION:

What immunotherapy drugs have shown promise in treating lung cancer?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: